SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-275897
Filing Date
2022-11-02
Accepted
2022-11-02 17:00:59
Documents
12
Period of Report
2022-10-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d393292d8k.htm   iXBRL 8-K 24770
  Complete submission text file 0001193125-22-275897.txt   142379

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA srpt-20221031.xsd EX-101.SCH 2858
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20221031_lab.xml EX-101.LAB 17237
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20221031_pre.xml EX-101.PRE 10814
6 EXTRACTED XBRL INSTANCE DOCUMENT d393292d8k_htm.xml XML 3230
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 221355040
SIC: 2834 Pharmaceutical Preparations